India’s drug regulator has approved Takeda Pharmaceutical’s dengue vaccine Qdenga, making it the first dengue vaccine to receive regulatory clearance in the country, the Japanese pharmaceutical company’s India unit announced on Monday. Takeda has partnered with Hyderabad-based vaccine manufacturer Biological E to produce Qdenga (TAK-003) in India. The two-dose vaccine is designed to protect children The post India approves first dengue vaccine developed by Japan’s Takeda appeared first on MM News.
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan